The company has established a large R&D laboratory with advanced facilities and has built and validated over 20 core technological platforms such as innovative antibody drug discovery, antibody engineering, and in vivo and in vitro drug efficacy evaluation. Sanyou provides biotechnology services that focus on the development of novel antibodies, and offers corresponding drug development solutions for biopharmaceutical companies to enable patients to receive better and more precise treatment. Sanyou is committed to establishing an internationally leading high-quality, high-throughput and integrated R&D and value transformation platform for innovative biological drugs, and has built a business system that integrates "differentiated CRO, innovative CPO and characteristic CRS".